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ABSTRACT
Background and Objectives: The objectives of this
study were to assess the impact of age following laparo-
scopic fundoplication (LF).
Methods: From March 1993 to November 1998, 193
patients underwent LF. Patients comprised 150 young
individuals (age<60; median 41) and 43 older individuals
(age>60; median 68). Follow-up included heartburn
scores, dysphagia scores, and quality of life determined
by the Short Form 36 Health Survey (SF36).
Results: Older patients had more cardiac disease, psy-
chiatric disorders, prior cancers, and upper abdominal
operations (P<0.05). DeMeester scores were similar
(young 70/older 69). Complications occurred in 13
(8.7%) of the young and 5 (11.6%) of the older patients
(P=0.142). No perioperative deaths occurred. Length of
stay was longer (P<0.000) in older patients (2.9 versus
1.6 days); resumption of oral intake (young–1.2;older–1.3
days) and return to normal activity (young–3.6;older–4.4
weeks) were similar. Follow-up was available in 102
young (median 17 months) and 35 older (median 18
months) patients. Heartburn and dysphagia scores were
excellent in both groups. SF36 scores were similar in
both groups. Only 6 (5.9%) of the young group and 1
(2.9%) of the older group were dissatisfied (P=0.652).
Conclusions: Despite differences in comorbid disease,
outcomes were similar in both groups. LF should be con-
sidered a therapeutic option in the older patient with
reflux.
Key Words: Gastroesophageal reflux, Outcomes,
Antireflux operation, Elderly.
INTRODUCTION
Gastroesophageal reflux disease (GERD) is one of the
most common chronic disorders of the gastrointestinal
(GI) tract that affects about 44% of Americans to some
degree, with an estimated 18% of patients using nonpre-
scription drugs.1 The majority of patients will get symp-
tomatic relief with proton pump inhibitors (PPI); howev-
er, some patients will continue to remain symptomatic,
or develop a complication of reflux, such as erosive
esophagitis, bleeding, stricture or Barrett’s disease that
will require surgical intervention. In young patients who
are facing life-long PPI therapy, surgery is usually under-
taken. In an older population, the role of surgery is more
controversial. This study was performed to assess the
impact of age on outcomes after minimally invasive
antireflux surgery performed at our center. In particular,
we wished to compare the effect of surgery on quality of
life (QOL). 
MATERIALS AND METHODS
A retrospective analysis was performed of patients oper-
ated on over a 5-year period (March 1993 through
November 1998). Our standard operative approach has
been previously described.2 Briefly, this includes full
crural dissection, approximation of the crura posterior to
the esophagus, division of the short gastric arteries,
removal of the esophageal fat pad, and a 360° wrap per-
formed over a bougie (48-60 F). Since April 1998, a Collis
gastroplasty3 performed laparoscopically has been
included, if a tension-free wrap around at least 2 cm to
3 cm of intraabdominal esophagus below the diaphragm
is not possible.
Patients were divided into 2 groups based on the defini-
tion in section 3002 of the Older Americans Act, which
defines “older individuals” as an individual of 60 years of
age or older. The young group included patients less
than 60 years and the older group included patients 60
years or above. Detailed outcome measurements includ-
ed heartburn severity determined by using the gastroe-
sophageal Reflux Disease-Health Related Quality of Life
Scale (HRQOL). This is a disease-specific instrument
designed by Velanovich et al,4 which consists of 10 ques-
tions. Nine relate to aspects of GERD with each response
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scored from 0 to 5. The best possible score is 0, and the
worst possible score is 45. Initial reports of this instru-
ment suggest preoperative scores of 28. The tenth ques-
tion relates to an overall assessment of satisfaction.
Dysphagia was recorded by using a scale from 1 (no dys-
phagia) to 5 (severe dysphagia). The Short Form 36
Health Survey (SF36) was used as a measure of global
QOL. This instrument designed by Ware and
Scherbourne5 has been extensively validated and tested
with population normal values identified.
SF36 responses were entered into an outcomes analyzer
program (Assist Technology, Scottsdale, Arizona). From
these raw scores, physical component summary scores
(PCS) and mental component summary scores (MCS)
were calculated. The United States normal values for both
the PCS and MCS scores is 50.
The data were analyzed by Mann-Whitney U tests to test
for outcome differences between young and older
patients.
RESULTS
Minimally invasive antireflux surgery was performed in
193 patients. This included 186 (96.4%) who underwent
laparoscopic Nissen fundoplication and 7 (3.6%) who
underwent laparoscopic Nissen fundoplication with the
addition of a Collis gastroplasty because of a shortened
esophagus. The young group included 150 patients with
a median age of 41 (range 15 to 59) years. Eighty-three
(55%) were men and 67 (45%) were women. The older
group included 43 patients with a median age of 68
(range 60 to 80) years. Twleve (28%) men and 31 (72%)
women were in this group. Mean preoperative
esophageal amplitude pressures and lower esophageal
sphincter pressures were 71 and 9.5 in younger patients
and 63 and 12.8 in older patients. DeMeester scores were
69 in the young group and 71 in the older group. GERD
symptoms were present for more than 12 months in 117
(78%) of the young group and 36 (84%) of the older
group. The older patients had a greater incidence of
comorbid diseases with more cardiovascular disease (30%
versus 8%, P=0.000), previously treated cancers 19% ver-
sus 5%, P=0.006), and a greater incidence of psychiatric
disorders (28% versus 13%, P=0.044). Additionally, the
older patients had a significantly (P<0.002) greater num-
ber of prior upper abdominal operations with 16 (37%)
compared with 20 (13%) in the younger group. The inci-
dence of Barrett’s disease was similar (P=0.849) for both
groups and was present in 37 (25%) of the young
patients and 10 (23%) of older patients.
No deaths occurred following surgery in either group.
Morbidity occurred in 13 (8.7%) of the younger and 5
(11.6%) of the older patients (P=0.142). These complica-
tions are outlined in Table 1. Two esophageal perfora-
tions occurred. In 1 patient, this was caused by the pas-
sage of a bougie in the proximal esophagus and was
repaired by thoracotomy. The second patient presented
with a delayed perforation, despite a normal postopera-
tive swallow. This required open surgery and drainage
with ultimately a successful outcome.
Mean length of stay was less (P=0.000) for the young
group at 1.6 compared with 2.9 days for the older group.
Time to oral intake was similar (P=0.140) for the younger
group (1.2 days) and older group (1.3 days). Return to
normal activity was also similar (P=0.226) for young
patients (3.6 weeks) and older patients (4.4 weeks).
Detailed follow-up including the outcome measures of
heartburn severity and QOL were available in 137
patients (young 102/older 35) at a median of 17 (11 to
63) months for the younger patients and 18 (12 to 79)
months for the older patients. Typical reflux symptoms of
heartburn, regurgitation, waterbrash, dysphagia, and
chest pain are outlined in Table 2. No significant differ-
ences occurred between groups. No significant differ-
ences occurred in the requirement for proton pump
inhibitors (PPI), Cisapride, and H2 antagonists (Table 3).
Outcome scores are shown in Table 4. Mean heartburn
(HRQOL) scores were excellent in both groups. Mean
dysphagia scores were normal in both groups. PCS and
MCS scores were also similar when comparing both
groups to each other and also to United States normal
values.
Only 6 (5.9%) of the young patients and 1 (2.9%) of the
older patients were dissatisfied (P=0.652). Reoperation
was required in 3 young group patients. Two patients
had slipped wraps. Both of these reoperations were per-
formed laparoscopically, with 1 reoperation including a
Collis gastroplasty. The third patient underwent reopera-
tion at another facility.
DISCUSSION
Since the first Nissen fundoplication was performed
laparoscopically in 1991,6 the number of centers per-
forming this procedure has increased at an exponentialrate. Laparoscopic fundoplication has been shown to be
a safe procedure that can be performed with acceptable
early results. Perdikis et al7 pooled the data from several
reports and demonstrated that in 2453 patients, overall
mortality was 4 (0.2%) and that intraoperative complica-
tions occurred in 104 (4.2%) patients of which 25 (1%) of
the complications were esophageal perforations. The
exact incidence of postoperative complications was not
detailed in this report, although some of these complica-
tions were described. Our early results are in keeping
with this and other reports, with no mortality in either
surgical group and complications occuring in 8.7% of
younger patients and 11.6% of older patients.
The role of surgery, however, remains controversial, par-
ticularly for older patients. Heudebert et al8 published a
cost-utility analysis comparing LF to PPI use. Their con-
clusions were that medical therapy should be the pre-
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ferred treatment strategy for most patients, with LF being
reserved for good candidates with a long life expectan-
cy. GERD, however, appears to occur more frequently in
older populations.9 Additionally, the severity of GERD is
worse, with more esophagitis and Barretts disease report-
ed,10 although this was not seen in our study. A review
of the outpatient database of a large health maintenance
organization (HMO) demonstrated an increasing preva-
lence of GERD in patients greater than 65 years of age.11
Additionally, the authors estimated that for the 2.4 mil-
lion members enrolled in the HMO, the annual expendi-
ture for acid-related diseases was 59.4 million dollars
with 40.6% of this required for the treatment of GERD.
Apart from the issues of the prevalence of GERD, treat-
ment costs, and disease severity, QOL should also be
considered when surgery is planned. Many GERD
patients will require daily medications. In many cases,
Table 1.
Postoperative Complications
Complication Young Group Older Group
(Occurred in 13/150 ) (Occurred in 4/43)
Esophageal perforation 1 1
Pneumothorax 1 1
Diaphragm avulsion 1 0
Atrial fibrillation 1 0
Atelectasis 3 1
Pneumonia 1 0
Clostridium difficile colitis 0 1
Pulmonary embolus 3 1
Superficial wound infection 1 0
Pancreatitis 0 1
Gastric dilation 1 0
Readmission dehydration/vomiting 2 0
Table 2. 
GERD Symptoms Present at Follow-up
Group Heartburn Regurgitation Waterbrash Dysphagia Chest Pain
Young (n=102) 24 (24%) 9 (9%) 9 (9%) 17 (17%) 14 (14%)
Older (n=35) 9 (26%) 4 (11%) 5 (14%) 3 (9%) 6 (17%)
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size and frequency will need to be periodically increased
with only partial relief of symptoms. Because older
patients will have a greater incidence of comorbid dis-
eases, with potentially increased operative risk, referring
physicians are often reluctant to refer these patients for
operation. Minimally invasive fundoplication, however,
offers the opportunity to effectively control symptoms
with acceptable risk, and significantly improve QOL.
Initial evaluation indicated a higher than expected recur-
rence rate of heartburn symptoms for both groups.
However, this may have been due to the close nature of
follow-up with symptom questionnaires. This has been
seen in a recent study from Sweden,12 comparing open
fundoplication with medical treatment where a failure
rate of 31% was reported on the symptom questionnaire.
Although 25% of our patients reported some heartburn,
this was felt to be mild in nature. In both surgical groups,
follow-up mean heartburn scores were only 3 on a scale
from 0 to 45, indicating excellent heartburn control.
Additionally, global QOL scores using the SF36 were sim-
ilar when both groups were compared with each other
and with United States normal values. Only 5.9% of the
younger group and 2.9% of the older group were dissat-
isfied with their treatment results.
CONCLUSION
In summary, our study demonstrates a higher incidence
of comorbid disease in the older patient group, which
was not unexpected. Despite these differences, laparo-
scopic fundoplication was associated with equally good
outcomes as seen in the younger patient group.
Minimally invasive fundoplication should be considered
a therapeutic option in the older patient with sympto-
matic GERD
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